We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > checkpoint inhibitors

News List

Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK pharmatimes
December 24, 2018
Merck’s latest Keytruda approval isn’t necessarily a huge one for the New Jersey drugmaker when it comes to sales. But it’s a big deal for Pfizer and Merck KGaA, maker of rival drug Bavencio.
Roche pays €70M upfront for Tusk’s preclinical Treg depleter fiercebiotech
September 29, 2018
Roche has paid €70 million ($81 million) upfront to buy Tusk Therapeutics. The takeover gives Roche control of an anti-CD25 antibody that depleted levels of regulatory T cells (Tregs) in preclinical tests.
Chinese biotech Harbour lands $85M to run cancer trials fiercebiotech
August 28, 2018
Shanghai-based biotech Harbour BioMed has raised $85 million (€73 million).